IBM, Shares

IBM Shares: Rebuilding Investor Confidence Amid AI Disruption

02.03.2026 - 05:15:19 | boerse-global.de

IBM faces investor fears over AI competition threatening its legacy COBOL business, despite a major DoD contract and solid financials including a dividend hike.

International Business Machines Corporation is navigating a period of significant market volatility. The technology giant is responding to its steepest single-day decline in more than a quarter-century with operational moves and strategic board appointments. However, underlying investor concerns persist regarding the viability of its traditional business model against a backdrop of aggressive competition in artificial intelligence.

Operational Moves Counter Market Sentiment

Despite the challenging climate, IBM continues to secure substantial business. At the start of the month, the company announced a $112 million contract with the Department of Defense to modernize pricing systems across global military installations. In a parallel move to bolster governance, the board has appointed PepsiCo CEO Ramon Laguarta as a new director. These actions are designed to project stability and shift focus toward the company's execution capabilities.

The Lingering Impact of an AI Announcement

Market attention remains fixed on February 23, a date that triggered a historic sell-off. On that day, IBM's equity plummeted over 13%. The catalyst was AI firm Anthropic and its new "Claude Code" tool, which promises the automated modernization of the legacy COBOL programming language. Given that many IBM mainframes and core banking systems still rely on COBOL, investors fear for the lucrative maintenance and consulting revenue that has long served as a defensive moat for the company.

Analyst perspectives on the severity of the drop are divided. Some market experts caution that IBM's consulting segment could face erosion, while other strategists point out that the company already offers its own modernization tools through the "watsonx" platform. Year-to-date, the stock remains under considerable pressure, trading approximately 18% lower and significantly underperforming the broader market.

Should investors sell immediately? Or is it worth buying IBM?

Financial Fundamentals Provide a Base

From a financial standpoint, IBM presents a solid picture irrespective of the AI-related anxieties. Its most recent quarterly results surpassed expectations, with revenue reaching $19.69 billion. Furthermore, the firm reaffirmed its status as a "Dividend Aristocrat" by announcing its 30th consecutive annual dividend increase. The sharp share price decline has prompted mixed analyst reactions: UBS upgraded the stock to "Neutral," citing a more attractive risk-reward profile, whereas Morgan Stanley reduced its price target.

Looking ahead, margin performance within the consulting division will be a critical focal point. Should clients begin adopting external AI tools for code modernization instead of IBM's consulting services, the multi-billion dollar segment could experience meaningful revenue contraction. The company must demonstrate that its own AI and hybrid cloud growth strategy can generate sufficient momentum to offset any potential declines in its legacy operations.

Ad

IBM Stock: New Analysis - 2 March

Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated IBM analysis...

Hol dir jetzt den Wissensvorsprung der Aktien-Profis.

Hol dir jetzt den Wissensvorsprung der Aktien-Profis.

Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt kostenlos anmelden
Jetzt abonnieren.

US4592001014 | IBM | boerse | 68626267 |